APOE and Alzheimer disease: The three major AD risk factors—age, female sex, and APOE4 genotype—have a profound impact on brain bioenergetics [18], resulting in glucose hypometabolism [36], down-regulation of mitochondrial genes involved in OXPHOS [50], altered Aβ processing and decline in regenerative capacity [19–21].